Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality
Author(s) -
Laura J. Rojas,
Madiha Salim,
Eric Cober,
Sandra S. Richter,
Federico Pérez,
Robert A. Salata,
Robert C. Kalayjian,
Richard Watkins,
Steve H. Marshall,
Susan D. Rudin,
Tatiana Domitrovic,
Andrea M. Hujer,
Kristine M. Hujer,
Yohei Doi,
Keith S. Kaye,
Scott Evans,
Vance G. Fowler,
Robert A. Bonomo,
David van Duin
Publication year - 2016
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciw805
Subject(s) - colistin , klebsiella pneumoniae , medicine , polymyxin , microbiology and biotechnology , carbapenem , antimicrobial , antibiotics , biology , escherichia coli , biochemistry , gene
Polymyxins including colistin are an important "last-line" treatment for infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKp). Increasing use of colistin has led to resistance to this cationic antimicrobial peptide.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom